Giovanni Abbadessa

Company: Sanofi
Job title: Vice President, Head of Oncology Early Development
Seminars:
Live Presenter Q&A 4:25 pm
Ask the speakers your most burning questions!Read more
day: Day Two
THOR-707, a Novel Non Alpha IL-2, in Patients with Advanced/ Metastatic Solid Tumors 4:05 pm
Hypothesis: why non alpha • Features: how THOR-707 spares the alpha receptor while binding to the beta-gamma receptor • Data: preliminary results from the ongoing Phase 1-2 clinical trial in patients with solid tumorsRead more
day: Day Two